Anti-TNF-α biologics are used in rheumatoid arthritis (RA) with varying success, but for other autoimmune diseases such as multiple sclerosis, anti-TNF-α therapy has been shown to exacerbate disease. The gene discussed is TNF; the disease is multiple sclerosis.